This track focuses on the intricate molecular pathways that contribute to oncogenesis. Participants will explore the genetic and epigenetic alterations that drive tumorigenesis.

This session will examine the latest epidemiological data on cancer incidence and prevalence across diverse populations. Discussions will include risk factors and their implications for public health.

This track will highlight recent advancements in the identification and validation of cancer biomarkers. Emphasis will be placed on their role in early detection and personalized medicine.

This session will focus on effective strategies for cancer prevention, including lifestyle modifications and vaccination programs. Participants will discuss the impact of public health initiatives on reducing cancer risk.

This track will explore novel therapeutic targets in cancer treatment, including targeted therapies and immunotherapies. The session aims to discuss the mechanisms of action and clinical implications of these treatments.

This session will address the disparities in cancer care and outcomes among different demographic groups. Participants will analyze the social determinants of health that influence access to treatment.

This track will delve into the application of genomic and proteomic technologies in understanding cancer biology. The focus will be on how these approaches can inform therapeutic decisions.

This session will provide insights into the design and implementation of clinical trials in oncology. Discussions will include challenges and opportunities in translating research findings into clinical practice.

This track will explore the role of palliative care in enhancing the quality of life for cancer patients. Participants will discuss strategies for managing symptoms and providing holistic support.

This session will focus on the latest technological advancements in cancer diagnosis, including imaging and liquid biopsy techniques. The potential for these technologies to revolutionize early detection will be emphasized.

This track will examine global initiatives and policies aimed at cancer control and prevention. Participants will discuss collaborative efforts and the role of international organizations in addressing the cancer burden.